Dexter, MI, United States of America

Paul Aristoff

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Lawrence Livermore National Security, LLC, Merck Sharp + Dohme Corp.. Active years: 2017-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Aristoff. Retrieved from https://idiyas.com/inventor/paul-aristoff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Paul Aristoff

Introduction

Paul Aristoff is an accomplished inventor based in Dexter, Michigan, known for his contributions to the field of pharmaceuticals. With a total of two patents to his name, Aristoff has made significant strides in developing compounds that serve as effective antibacterial agents.

Latest Patents

Aristoff's latest patents focus on tricyclic gyrase inhibitors. These patents disclose compounds that possess a specific structure, along with pharmaceutically suitable salts, esters, and prodrugs. These compounds are recognized for their antibacterial effectiveness, and the patents also contemplate related pharmaceutical compositions, uses, and methods for synthesizing these compounds.

Career Highlights

Throughout his career, Paul Aristoff has worked with notable organizations, including Lawrence Livermore National Security, LLC and Merck Sharp & Dohme Corporation. His experience in these companies has contributed to his expertise in pharmaceutical innovations.

Collaborations

Some of his notable coworkers include Daniel Bensen and Zhiyong Chen, who have collaborated with Aristoff on various projects.

Conclusion

Paul Aristoff's work in developing tricyclic gyrase inhibitors showcases his innovative spirit and dedication to advancing pharmaceutical science. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…